ArticleBiodegradation2025
Deciphering the constraints of pure bacterial strains for the complete catabolism of sulfamethoxazole: A proteomic and kinetic study.
Article in Biodegradation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic Specialization and Synergy in Alkane Degradation By a Microbial Consortium: An Integrated Genomic and Geochemical Approach.Current microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Organic micropollutants (OMP) pose a significant environmental challenge, and microbial degradation research typically involves monitoring parent compound depletion and metabolite production. Previous studies on the antibiotic sulfamethoxazole (SMX) have shown its incomplete biotransformation by either mixed microbial communities or acclimated pure bacterial across various concentrations. However, the mechanisms behind this incomplete degradation and its relationship with the enzymatic capacities and expressions at environmentally relevant concentrations remain unclear. Therefore, this study investigated the biotransformation of SMX and the variations in the proteome at low µg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.